Circle (CRCL) Q4 2025 Earnings Call Transcript

Earlier this morning, we posted our earnings press release and earnings presentation on the Circle Investor Relations website, investor.circle.com. Jeremy Allaire: Thank you, John, and good morning, ...
WISH-TV

‘Shining a Light’ presentation on Monument Circle to celebrate Hispanic Heritage Month

INDIANAPOLIS (WISH) — Hoosiers can celebrate Hispanic Heritage Month with a special “Shining a Light” presentation on Monument Circle. “Shining a Light” is a vibrant light and multimedia presentation ...
Morningstar

Circle Pharma Announces Poster Presentation Highlighting the Potential of CID-078, a First-in-class Oral Cyclin A/B RxL Inhibitor, at the American Association for Cancer ...

Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced an upcoming poster presentation highlighting the ...
WISH-TV

‘Shining a Light’ presentation on Monument Circle honors MLK

INDIANAPOLIS (WISH) — Hoosiers can continue to celebrate the legacy of Dr. Martin Luther King Jr. with a special tribute for Black History Month. “Shining a Light” is a vibrant light and video show ...
Business Wire

Circle Pharma Announces Upcoming Presentation at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

SAN FRANCISCO--(BUSINESS WIRE)--Circle Pharma, a biopharmaceutical company advancing the discovery and development of intrinsically cell-permeable macrocycles, today announced an upcoming poster ...
VentureBeat

Preclinical Data on Circle Pharma’s CID-078 Featured in Poster Presentation at Advances in Neuroblastoma Research Meeting

Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation of preclinical data on CID-078 at the ...